Clinical Trials Database Auditors Wary Of Liability Risk, GSK Attorney Says
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline is having difficulty finding independent auditors willing to take the responsibility for confirming the contents of the company's clinical trial results database, U.S. VP-R&D Legal Operations Tom Merchant says